Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000245934

Medchemexpress LLC Orbofiban acetate | 163250-91-7 | 98.1% | 421.45 g/mol | C19H27N5O6 | 50 MG
SDP

Catalog No. 5000245934
Encompass_Preferred

Orbofiban acetate is an orally active platelet GPIIb/IIIa antagonist used in research to inhibit platelet aggregation. It is supplied as a purified acetate salt for laboratory and preclinical studies, with accompanying documentation to support safe handling and compound characterization.

  • Orally active GPIIb/IIIa antagonist that inhibits platelet aggregation.
  • High purity (98.13%) suitable for research applications.
  • Molecular weight 421.45 g/mol; chemical formula C19H27N5O6.
  • Supplied in a 50 mg quantity for laboratory use.
  • Documentation available: datasheet, certificate of analysis, and safety data sheet.

Catalog No. 50-002-45934 Supplier Medchemexpress LLC Supplier No. HY10304A50MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Orbofiban acetate is an orally active platelet GPIIb/IIIa antagonist used in research to inhibit platelet aggregation. It is supplied as a purified acetate salt for laboratory and preclinical studies, with accompanying documentation to support safe handling and compound characterization.

  • Orally active GPIIb/IIIa antagonist that inhibits platelet aggregation.
  • High purity (98.13%) suitable for research applications.
  • Molecular weight 421.45 g/mol; chemical formula C19H27N5O6.
  • Supplied in a 50 mg quantity for laboratory use.
  • Documentation available: datasheet, certificate of analysis, and safety data sheet.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.